INS and diabetes mellitus: A recent analysis of PCI patients from New York confirmed these findings in more actual data: At one year, diabetes was associated with a 2.1× elevation in adverse event rates (MACE) in insulin-treated DM (ITDM) and with a HR of 1.27 in non-ITDM after PCI [20].